E-cigarettes have not been proven to cause lung cancer, but they do damage lung tissue in ways that may increase risk over time

The short answer: we do not yet know if e-cigarettes cause lung cancer. No large study has followed e-cigarette users long enough to measure cancer rates the way we did for cigarettes. What we do know is that vaping damages the cells lining your lungs, causes inflammation, and introduces chemicals into lung tissue that can harm DNA. Whether that damage adds up to cancer depends on how much you vape, for how long, and what is in the liquid you use.

E-cigarettes are newer than traditional cigarettes by decades. Cigarettes took 50 years of study before the link to lung cancer was clear. E-cigarettes have been in widespread use for only about 15 years. The damage is real and measurable now. The cancer risk is the part we cannot yet measure.

Key Takeaways

  • E-cigarette vapor contains chemicals that damage lung cells and cause inflammation, even though it lacks the tar and combustion byproducts of burned tobacco.
  • Propylene glycol and vegetable glycerin—the base liquids in most e-cigarettes—break down into formaldehyde and other irritants when heated, and formaldehyde is a known carcinogen.
  • Nicotine itself does not cause cancer, but it can weaken immune function in the lungs and may make existing damage harder to repair.
  • The longer and more heavily someone vapes, the more lung tissue is exposed to these chemicals, which increases theoretical cancer risk even if we cannot yet measure it in humans.
  • Switching from cigarettes to e-cigarettes reduces some cancer risks but does not eliminate them, and starting with e-cigarettes carries different risks than cigarettes do.

What happens to lung cells when you inhale e-cigarette vapor

When you vape, you are inhaling a heated mist, not smoke. That matters—combustion creates thousands of chemicals that burning tobacco does. But heating does damage too. The base liquid in most e-cigarettes is propylene glycol, vegetable glycerin, or both. When these are heated to the temperature an e-cigarette reaches, they break down into formaldehyde, acetaldehyde, and other compounds. Formaldehyde is classified as a human carcinogen by the International Agency for Research on Cancer.

The cells lining your lungs—called the epithelium—are designed to filter and protect. When exposed to e-cigarette vapor repeatedly, these cells become inflamed. Inflammation itself is not cancer, but chronic inflammation is a known pathway to cancer development. Studies of people who vape show increased markers of inflammation in their lungs compared to people who do not vape. The longer the exposure, the more pronounced the inflammation.

E-cigarettes also contain nicotine, which does not directly cause cancer but does affect immune function. Nicotine can suppress the activity of immune cells in the lungs that normally patrol for damaged or abnormal cells. This means your lungs may be less able to catch and eliminate cells that have been harmed by the chemicals in vapor.

How the chemicals in e-liquid vary the risk

Not all e-liquids are the same. The nicotine concentration varies widely—from zero to over 50 milligrams per milliliter. Higher nicotine means more frequent vaping for some users and more chemical exposure overall. The flavorings added to e-liquid also matter. Some flavorings, like diacetyl (used in butter flavoring), have been linked to lung disease. Others have not been studied in the context of inhalation.

Counterfeit or unregulated e-liquids may contain heavy metals, pesticides, or other contaminants. Even regulated products vary in quality. A liquid labeled as containing only propylene glycol, vegetable glycerin, nicotine, and flavoring may still produce formaldehyde and other breakdown products when heated—and the amount depends on the device temperature, which users can often adjust.

Some e-cigarettes heat liquid to higher temperatures than others. Higher heat produces more formaldehyde. Users who prefer a "hotter" vape or who use high-wattage devices are exposing their lungs to more of these chemicals per puff than someone using a lower-temperature device.

Why we cannot yet say e-cigarettes cause lung cancer

Lung cancer typically takes 20 to 30 years to develop after exposure to a carcinogen. E-cigarettes have been in common use for roughly 15 years. No study has followed a large group of e-cigarette users from the start of their use through to cancer diagnosis or non-diagnosis. Without that data, we cannot calculate a cancer rate or compare it to the rate in people who do not vape.

Laboratory studies show that e-cigarette vapor damages lung cells and can cause mutations in DNA—the kind of damage that can lead to cancer. But laboratory damage does not always become cancer in living people. The body has repair mechanisms. Some people exposed to carcinogens develop cancer; others do not. We do not yet know what fraction of long-term e-cigarette users will develop lung cancer, or at what age.

This does not mean e-cigarettes are safe. It means the cancer risk is not yet quantified. The damage is real. The risk is plausible. The proof is incomplete.

E-cigarettes versus cigarettes: different risks, not zero risk

Traditional cigarettes cause lung cancer in a large fraction of long-term smokers—roughly 10 to 15 percent of people who smoke a pack a day for 30 years. Cigarettes produce tar, carbon monoxide, and thousands of other chemicals through combustion. E-cigarettes do not produce tar or carbon monoxide. In that sense, they are less harmful than cigarettes.

But "less harmful" is not the same as "harmless." A person who switches from cigarettes to e-cigarettes reduces their exposure to some carcinogens but continues to expose their lungs to others. The net benefit depends on how much they smoked before, how much they vape now, and whether they eventually quit nicotine altogether.

Someone who has never smoked and starts vaping is taking on a cancer risk they would not otherwise have. Someone who smokes cigarettes and switches entirely to e-cigarettes is likely reducing their cancer risk compared to continuing to smoke, but not eliminating it. Someone who uses both cigarettes and e-cigarettes is exposed to the risks of both.

What the research shows so far

Studies of animals exposed to e-cigarette vapor show lung inflammation, airway damage, and changes in immune function. Some studies have found precancerous changes in lung cells exposed to e-cigarette vapor in the laboratory. None of these findings prove that e-cigarettes cause cancer in humans, but they show the biological pathway is plausible.

Human studies are limited. Researchers have measured inflammation markers, immune changes, and DNA damage in people who vape. All of these are associated with cancer risk in other contexts. But association is not proof. A person with inflammation in their lungs may or may not develop cancer. We will not know the actual cancer rate until we have decades of follow-up data.

One large study published in 2023 found no increase in lung cancer diagnosis among e-cigarette users in the first 10 years of use, but the study was limited to people who had used e-cigarettes for less than a decade. That is not long enough to detect a cancer signal if one exists.

What you can do to reduce lung risk if you vape

If you use e-cigarettes and want to reduce potential harm, lower nicotine concentration reduces the frequency of vaping and total chemical exposure. Using a device with lower temperature settings produces less formaldehyde. Buying from regulated manufacturers rather than unregulated sources reduces the risk of contaminants.

The most effective way to reduce lung cancer risk from vaping is to stop vaping. If you are using e-cigarettes to quit smoking, that trade-off may be worth it in the short term—the cancer risk from cigarettes is much higher and more certain. If you are using e-cigarettes recreationally or to manage nicotine addiction, quitting entirely eliminates the risk.

If you have been vaping for years and are concerned about lung damage, talk to your doctor about whether lung screening is appropriate for you. Screening is not standard for e-cigarette users the way it is for heavy smokers, but your doctor can assess your individual risk based on how much you have vaped and for how long.

Frequently Asked Questions

Is nicotine itself a carcinogen?

Nicotine is not classified as a carcinogen by major health agencies. It is highly addictive and affects the nervous system, but it does not directly cause cancer. However, nicotine can suppress immune function in the lungs, which may make it harder for your body to repair damage caused by other chemicals in e-cigarette vapor.

Can secondhand e-cigarette vapor cause lung cancer?

Secondhand exposure to e-cigarette vapor is much lower than direct inhalation, and no study has shown that secondhand vaping causes lung cancer. However, bystanders do inhale some of the same chemicals vapers do, including nicotine and formaldehyde. The long-term risk from secondhand exposure is unknown.

If I quit vaping now, will my lungs heal?

Lungs have some capacity to repair damage, especially if the exposure stops. Inflammation decreases within weeks to months after quitting. However, if DNA damage has already occurred, quitting does not undo that damage—it only stops new damage from happening. The earlier you quit, the more healing your lungs can do.

Are there types of e-cigarettes that are safer than others?

Lower-temperature devices produce less formaldehyde than high-temperature ones. Devices with adjustable wattage allow you to use lower heat. Regulated products from established manufacturers are more likely to contain what the label says. But no e-cigarette is risk-free—all of them expose your lungs to chemicals that cause inflammation and DNA damage.